• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - pregnancy
Tag:

pregnancy

Health

Racial Disparities in Hypertension Onset Among Women

by Chief Editor July 3, 2026
written by Chief Editor

Black women in the United States develop hypertension nearly a decade earlier than their White counterparts, a gap that persists regardless of neighborhood socioeconomic conditions. According to a study published in JAMA Network Open, researchers tracking 15,313 women found that Black women reach a median age of hypertension onset at 56, compared to 66 for White women.

Why Does the Hypertension Gap Persist Across Neighborhoods?

The study, which utilized data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, indicates that neighborhood disinvestment does not fully explain racial disparities in high blood pressure. While living in highly disinvested areas—defined by lower household income, housing values, and educational status—lowers the age of onset for all women, the racial gap remains significant.

Why Does the Hypertension Gap Persist Across Neighborhoods?

In neighborhoods with low disinvestment, Black women develop hypertension a median of 9.2 years earlier than White women. In areas characterized by high disinvestment, that gap narrows to 8 years. Researchers suggest this persistence indicates that structural drivers of cardiovascular health inequities extend beyond local geography, likely involving chronic, race-linked stressors that occur regardless of a neighborhood’s economic status.

Did you know?
The REGARDS study analyzed 15,313 participants between 2003 and 2016. Researchers found that 82.7% of Black women in the cohort developed hypertension, compared to 62.2% of White women.

How Do Biological and Social Factors Influence Early Onset?

High blood pressure is a primary driver of cardiovascular disease, and its trajectory is often more severe in women. According to the study authors, biological shifts tied to pregnancy, menopause, and gynecological health, combined with social stressors such as caregiving and experiences of sexism, contribute to this risk.

How Do Biological and Social Factors Influence Early Onset?

For Black women, these factors are often compounded by cumulative physiological stress. The study suggests that the accelerated aging profile observed in Black women—often appearing as early as age 45—may be the result of a lifetime of navigating demanding coping strategies in the face of structural inequities. Unlike White women, whose age of onset shifted when researchers adjusted for health factors like exercise and rurality, the median age of onset for Black women remained largely stable, suggesting that individual lifestyle changes alone are insufficient to close the gap.

What Are the Implications for Future Prevention?

Current clinical guidelines may fail to account for the accelerated cardiovascular risk profile of Black women. Because the condition manifests nearly 10 years earlier, the authors argue that prevention strategies must begin much earlier in the life course.

What Are the Implications for Future Prevention?

Pro tip: Physicians should consider early screening for patients in high-risk demographics, as the standard age for hypertension monitoring may miss early-stage development in populations experiencing chronic systemic stress.

Limitations of the Research

While the study provides a large-scale look at longitudinal health data, the authors noted several limitations. Because the cohort focused on adults 45 and older, the findings do not capture the onset of hypertension in younger populations. Additionally, the study relied on a mix of self-reported physician diagnoses and measured blood pressure, which could introduce some classification bias. Future research is required to isolate how specific neighborhood conditions versus persistent, non-neighborhood-based racial stressors contribute to these outcomes.

Frequently Asked Questions

  • Is hypertension more common in women than men?
    Older women are more likely to develop hypertension and often face greater challenges in achieving adequate blood pressure control compared to men of the same age, according to the study.
  • Does living in a better neighborhood eliminate the racial gap in hypertension?
    No. While neighborhood disinvestment impacts the age of onset for both groups, the study found that Black women still developed hypertension significantly earlier than White women, even in neighborhoods with high resource allocation.
  • What is “neighborhood disinvestment”?
    It refers to low resource allocation caused by inequitable planning and policy decisions, typically measured by census-tract data including household income, education levels, and housing values.

Have you or a loved one navigated early-onset hypertension? Share your experiences in the comments below or subscribe to our newsletter for more updates on cardiovascular health research.

July 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Neuroticism and Adversity: Key Drivers of Depression and Anxiety Risk

by Chief Editor June 26, 2026
written by Chief Editor

Psychosocial factors like neuroticism and life adversity contribute more to the population burden of depression and anxiety than physiological factors, according to a 13-year study in Translational Psychiatry. Using UK Biobank data, researchers found psychosocial elements account for up to 67% of the depression burden in men and 61% in women.

Why do psychosocial factors drive the majority of depression and anxiety cases?

The study identifies neuroticism symptoms as the single largest contributor to the depression burden. Researchers calculated a population-attributable fraction (PAF) of 49% to 60% for depression and 52% to 54% for anxiety related to neuroticism symptoms.

Life adversity also plays a significant role in mental health outcomes. Adverse experiences in childhood and adulthood carry a PAF of 18% to 25% for depression and 11% to 14% for anxiety, according to the researchers. These events can disrupt stress responses and cause emotional dysregulation.

While women are generally more prone to neuroticism, the association between neuroticism and depression was stronger in men. Men with these symptoms were 3.5 times more likely to develop depression, compared to a 2.6-fold increase for women.

Did you know?
The study suggests that if modifiable risk factors were addressed, the combined population-attributable fraction for depression could be as high as 70% in men and 68% in women.

How do obesity and reproductive health impact mental health risks?

Physiological factors remain significant, though they contribute less to the overall population burden than psychosocial ones. Obesity carries a 15% PAF for depression in both sexes. Obese women face a 33% higher risk of depression, while men face a 25% higher risk.

The role of chronic inflammation and diabetes

Chronic inflammation is linked to increased risks for both disorders. The study found PAFs for depression ranged from 6% to 7%, while anxiety risks ranged from 3% to 5%. Diabetes also increases depression risk, though its PAF remains below 3%.

Reproductive factors in women

For women, hormone replacement therapy (HRT) showed a PAF of 13% for depression and 9% for anxiety. Other factors, such as early menarche and pregnancy termination, also contributed to depression risk.

The impact of reproductive factors differs significantly between the two conditions. While reproductive factors contributed 19% to the depression burden, they had a minimal impact on anxiety, with a combined PAF of just 0.13%.

What are the limitations of the UK Biobank study?

The researchers noted several caveats regarding the data. Because the study was observational, it cannot prove that these factors cause depression or anxiety. The data relied on retrospective self-reporting for childhood and adult adversity, which can lead to recall bias.

Additionally, the UK Biobank is not a representative sample of the general population. The study also used “yes/no” categorizations for several variables, which may have prevented researchers from observing dose-response relationships.

What does this mean for future mental health prevention?

The findings suggest a move toward “sex-sensitive, life course-oriented strategies.” This involves integrating psychological, metabolic, and reproductive health into standard clinical practice.

What does this mean for future mental health prevention?

The researchers suggest several potential intervention strategies:

  • Targeting trauma and socioeconomic stress.
  • Screening for mental health during menopause.
  • Monitoring mental health in patients with chronic diseases.
Pro Tip:
Clinicians are increasingly looking at “whole-person” health, combining metabolic monitoring with psychological support to manage long-term mental health risks.

Frequently Asked Questions

What is the primary driver of depression according to the study?

Psychosocial factors, specifically neuroticism and life adversity, are the strongest contributors to the population burden of depression.

What is the primary driver of depression according to the study?

Does obesity cause depression?

The study shows an association, with obesity contributing to a 15% population-attributable fraction for depression, but it does not prove a direct causal link.

Are women at higher risk for anxiety than men?

The study notes women are nearly twice as likely to be diagnosed with depression and anxiety, though the specific risk drivers vary by sex.

Want to stay updated on the latest mental health research? Leave a comment below with your thoughts on these findings or subscribe to our newsletter.

June 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

How Weed Killers Affect Pregnancy: Mapping Biological Pathways

by Chief Editor June 16, 2026
written by Chief Editor

Exposure to glyphosate, the active ingredient in many weed killers, is linked to changes in hormones that support pregnancy and fetal development, according to a University of Michigan School of Public Health study. Researchers observed shifts in estriol, thyroid hormones, and corticotropin-releasing hormone among 752 pregnant women in Puerto Rico.

How does glyphosate exposure affect hormones during pregnancy?

The study, published in the Journal of Exposure Science and Environmental Epidemiology, identifies a connection between herbicide exposure and hormonal fluctuations necessary for a healthy pregnancy. Researchers tracked the levels of glyphosate and AMPA—the primary substance glyphosate breaks down into—in urine samples taken from participants at 18, 22, and 26 weeks of pregnancy.

How does glyphosate exposure affect hormones during pregnancy?

The findings suggest that these chemicals may disrupt the endocrine system through several specific pathways:

Estriol and thyroid hormone shifts

The research team noted a direct correlation between chemical levels and the hormone estriol, which is critical for maintaining pregnancy. According to the study data:

  • Moderate increases in AMPA were associated with a 10.6% decrease in estriol levels.
  • Moderate increases in glyphosate were linked to an 8.3% decrease in estriol levels.

Additionally, AMPA exposure was linked to higher levels of the thyroid hormone T3. As the pregnancy progressed, researchers found that AMPA was associated with higher thyroid-stimulating hormone, while glyphosate was linked to higher levels of corticotropin-releasing hormone (CRH), a hormone involved in the body’s stress response and the biological processes that trigger labor.

Did you know?

AMPA is the main environmental byproduct of glyphosate. Because it is highly persistent, it often appears in human biological samples even when the original glyphosate has already begun to degrade.

Why were exposure levels higher in Puerto Rico?

The study utilized data from the PROTECT birth cohort, a long-term study focused on environmental exposures and maternal health in Puerto Rico. Researchers found that glyphosate and AMPA were present in 70% of the urine samples collected during the study visits.

Mislael Valentín-Cortés, a postdoctoral research fellow at the University of Michigan and the study’s first author, noted that these exposure levels exceed what is typically reported for the general population in the United States. Valentín-Cortés stated that US territories often carry a disproportionate share of environmental burdens, which are frequently compounded by extreme weather events and infrastructure failures.

Can this study prove glyphosate causes pregnancy complications?

While the data shows a clear link, the researchers cautioned against assuming direct cause and effect. The study was observational, meaning it identifies correlations between chemical presence and hormone levels rather than proving the herbicide is the sole cause of the changes.

Cause of preeclampsia may have been discovered by University of Michigan researchers

There are several limitations to consider:

  • Recent Exposure: Urine samples reflect recent contact with chemicals rather than total exposure throughout the entire pregnancy.
  • Outcome Data: The study did not measure whether these specific hormonal changes directly resulted in preterm births or specific health issues for the children.

However, the findings provide a biological explanation for previous human studies that have linked glyphosate to preterm birth and differences in fetal growth. By identifying hormone disruption as a potential pathway, the research moves the discussion from general environmental concern to measurable physiological changes.

“This is the most extensively used herbicide in the world, yet there are shockingly few research studies on the potential impacts it may have on human reproductive health, pregnancy, or fetal and child development,” said John Meeker, professor of Environmental Health Sciences at the University of Michigan School of Public Health.

What happens next in environmental health research?

The University of Michigan research team plans to use future data collections to explore whether these hormonal shifts lead to specific birth outcomes or long-term health effects in children. As public interest in pesticide regulation grows, researchers are calling for more sustained attention to how common environmental exposures impact maternal and child health.

What happens next in environmental health research?
Pro Tip for Researchers:

When reviewing environmental health studies, always distinguish between observational data (which shows links) and experimental data (which can demonstrate causation).

Frequently Asked Questions

What is glyphosate?

Glyphosate is the active ingredient in many widely used weed killers. It is used extensively in farming, landscaping, and residential lawn care.

How can people be exposed to glyphosate?

Exposure can occur through contact with treated soil or plants, pesticide drift in the air, and through contaminated food or water sources.

Is glyphosate exposure common?

Yes. In the Puerto Rico study, glyphosate and its byproduct AMPA were found in 70% of the participants’ samples.

Stay Informed: Want to keep up with the latest developments in environmental health and public safety? Subscribe to our newsletter or browse our latest health reports to stay ahead of the curve.

June 16, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Postpartum Hypertension and Recurrent HDP Risk: A BU Study

by Chief Editor June 11, 2026
written by Chief Editor

Researchers at the Boston University School of Public Health (BUSPH) and Boston Medical Center (BMC) are launching a $3.2 million study to determine if monitoring postpartum blood pressure can prevent recurrent hypertensive disorders of pregnancy (HDP). Led by Dr. Samantha Parker Kelleher and Dr. Christina Yarrington, the five-year project aims to identify early interventions for the 10 percent of U.S. pregnancies affected by conditions like preeclampsia, according to the National Heart, Lung, and Blood Institute.

Why is the postpartum window critical for heart health?

Up to 50 percent of women who experience HDP develop hypertension in the six weeks following birth, creating a narrow but vital window for medical intervention. Dr. Samantha Parker Kelleher, principal investigator and associate professor of epidemiology at BUSPH, notes that current maternal healthcare often waits until the next pregnancy to address these risks. By shifting the focus to the immediate postpartum period, clinicians hope to stabilize patients before they conceive again, potentially lowering the 15-45 percent recurrence rate of HDP observed in the United States.

Why is the postpartum window critical for heart health?
Did you know?

Hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia, are strongly linked to long-term cardiovascular issues, such as chronic hypertension and stroke, according to data from BUSPH.

How does remote monitoring change patient care?

The study will analyze data from 3,500 BMC patients using a cloud-connected blood pressure cuff program that began during the COVID-19 pandemic. According to Dr. Erica Holland, an obstetrician-gynecologist at BMC, this technology allows clinicians to manage elevated readings remotely and trigger urgent in-person evaluations when necessary. This proactive approach aims to reduce hospital readmissions and severe complications like seizures. Because BMC serves a high percentage of underserved populations, researchers believe this model offers a scalable solution to address health disparities, as Black and Hispanic pregnant people are disproportionately affected by HDP.

How does remote monitoring change patient care?

Can breastfeeding reduce the risk of recurrent HDP?

Researchers are examining whether breastfeeding duration influences the likelihood of developing HDP in subsequent pregnancies. Dr. Katherine Standish, founder of BMC’s Breastfeeding and Lactation Medicine Center, explains that improved cardiovascular indicators have been observed as early as one month after initiating breastfeeding. While the study explores the benefits of lactation, it also acknowledges the barriers faced by mothers who are already managing acute hypertensive disease. The team intends to use these findings to identify which patients would benefit most from lactation support and determine the optimal timing for such interventions.

New study delves into pregnancy, maternal health

What are the next steps for clinical guidelines?

A primary goal of the project is to provide data that could redefine when antihypertensive medications are prescribed. Currently, the threshold for defining hypertension in the monitoring program is 140/90 mmHg, though it was previously 150/100 mmHg. By comparing patient outcomes across these different thresholds, the team hopes to inform future clinical guidelines. Dr. Parker Kelleher emphasizes that the ultimate goal is to get mothers into a “good position to have healthy, uncomplicated pregnancies” by addressing risk factors long before a new pregnancy begins.

Pro Tip:

If you are planning a future pregnancy after experiencing HDP, consult your primary care physician about early interventions. Low-dose aspirin is currently the only evidence-based preventive treatment for recurrent HDP, but it must be started early in the subsequent pregnancy to be effective.

Frequently Asked Questions

What is the most effective way to prevent recurrent HDP?
Currently, low-dose aspirin is the only evidence-based preventive treatment, provided it is prescribed early in a subsequent pregnancy.
How does postpartum hypertension affect future health?
Postpartum hypertension is a significant risk factor for chronic heart disease, stroke, and the recurrence of hypertensive disorders in future pregnancies.
Why is the postpartum period considered “underutilized” in care?
Traditional maternal care focuses heavily on the prenatal period. Researchers at BUSPH argue that the first six weeks after birth provide a unique opportunity to identify and treat risk factors before a woman becomes pregnant again.

Are you interested in learning more about maternal health innovations? Subscribe to our weekly newsletter for the latest updates on medical research and health policy.

June 11, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

How Fertility Challenges Affect Child Development and Behavior

by Chief Editor June 10, 2026
written by Chief Editor

A study published in JAMA Network Open suggests that parental fertility challenges—not IVF itself—are linked to small differences in children’s neurodevelopment. Researchers found that children of parents facing infertility showed higher odds of autism-like traits and ADHD, regardless of whether medical fertility treatments were used during conception.

What did the ECHO Cohort study reveal?

Researchers analyzed data from 15,382 mother-child pairs across 44 study sites in the United States and Puerto Rico. This research, funded by the National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) Program, tracked children between the ages of 2 and 10.

The study categorized pregnancies based on medical history, including infertility diagnoses, multiple miscarriages, and the amount of time spent trying to conceive. By combining medical records with parent-completed questionnaires, the team identified specific developmental patterns.

According to the study findings, children of parents with fertility challenges demonstrated slightly higher behavior-problem scores and more autism-like traits. These differences appeared even in children conceived without the use of fertility treatments.

Did you know? The ECHO Program is one of the largest collaborative research efforts in the U.S. designed to study how environmental factors affect child health from pregnancy through adolescence.

Is IVF responsible for neurodevelopmental differences?

A critical distinction emerged in the data regarding different types of fertility assistance. The research found that conception using non-in vitro fertilization (IVF) treatments was associated with higher odds of ADHD compared to natural conception.

However, the researchers did not find clear evidence linking IVF specifically to neurodevelopmental outcomes. This distinction is vital for families evaluating reproductive options.

Conception Method Associated Neurodevelopmental Finding
In Vitro Fertilization (IVF) No clear association found
Non-IVF Fertility Treatments Higher odds of ADHD
Fertility Challenges (No Treatment) Higher autism-like traits and behavior issues

Why are underlying fertility issues the likely cause?

The data suggests that the medical procedures used to achieve pregnancy may not be the primary driver of developmental differences. Instead, the biological or environmental reasons why a couple struggles to conceive may play a larger role.

Linda Kahn, PhD, an ECHO researcher at NYU Langone Health, noted that the associations likely stem from the parents’ original fertility problems. These underlying issues could be driven by genetic factors, environmental influences, or other biological drivers.

“This study contributes to the growing body of evidence indicating that infertility treatment itself is not independently associated with child neurodevelopment outcomes. Rather, it appears that the parents’ underlying fertility problems… are likely driving these associations.”
— Linda Kahn, PhD, NYU Langone Health

This finding shifts the focus for medical professionals. Future fertility counseling may prioritize identifying the root cause of subfecundity to better understand potential developmental contexts for future children.

Pro Tip: When discussing reproductive health with specialists, ask about the specific biological drivers of infertility. Understanding whether a challenge is genetic or environmental can provide a clearer picture of long-term health considerations.

Frequently Asked Questions

Does IVF cause autism in children?

According to the ECHO study, there is no clear evidence that IVF is associated with neurodevelopmental outcomes like autism.

2026 PAC Webinar: Clinical Conundrums in Pediatric Fertility Preservation

What is the link between ADHD and fertility treatments?

The study found that children conceived using non-IVF fertility treatments had higher odds of ADHD compared to those conceived naturally.

Does infertility alone affect child behavior?

Yes. The research indicates that children of parents with fertility challenges showed slightly higher behavior-problem scores and autism-like traits, even without medical intervention.

What do you think about these findings? Does this change how you view fertility treatments? Let us know in the comments below or subscribe to our newsletter for more updates on medical research.

June 10, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Mycoplasma Genitalium Linked to Low Risk of Recurrent Preterm Birth

by Chief Editor June 10, 2026
written by Chief Editor

A study published in The American Journal of Obstetrics and Gynecology reports that Mycoplasma genitalium (MGen) does not increase the risk of recurrent preterm birth. Researchers at UTHealth Houston, who followed nearly 500 pregnant individuals with prior complications, found that while the infection is common among those with history of preterm delivery, it does not act as a driver for subsequent early births.

Does MGen Cause Preterm Birth?

Current clinical data suggests that Mycoplasma genitalium does not directly trigger recurrent preterm birth. According to a prospective study led by Dr. Irene Stafford of UTHealth Houston, researchers tracked 500 pregnant individuals between July 2023 and December 2025 to determine the bacteria’s impact on pregnancy outcomes. While 12% of participants tested positive for the infection via FDA-cleared vaginal swabs, the presence of the bacteria did not correlate with an increased rate of spontaneous preterm delivery or second-trimester loss.

Did you know? Mycoplasma genitalium lacks a cell wall, a biological trait that makes the bacteria notoriously difficult to detect and treat compared to more common pathogens.

Why Does MGen Appear More Often in High-Risk Patients?

Although the infection does not cause recurrent preterm birth, it is statistically more prevalent in patients who have already experienced one. Dr. Stafford suggests that Mycoplasma genitalium may pose a higher risk during a first-time or “incident” infection. In these cases, the body has not yet developed an immune response, potentially leading to the inflammation that initially prompted researchers to investigate a link to pregnancy complications. This contrasts with earlier, limited research that hypothesized a broader, direct causal link between various Mycoplasma species and preterm labor.

View this post on Instagram about Recurrent Preterm Birth, Pro Tip
From Instagram — related to Recurrent Preterm Birth, Pro Tip

Future Trends in Prenatal Screening

The medical community is shifting toward more targeted screening protocols as antimicrobial resistance grows. Because Mycoplasma genitalium is increasingly resistant to standard treatments, public health experts emphasize the importance of distinguishing between infections that require intervention and those that are incidental. According to Dr. Stafford, the UTHealth Houston findings provide clinicians with the clarity needed to avoid unnecessary alarm for patients who test positive but are not at an elevated risk of a second preterm birth.

Pro Tip: If you are pregnant and have a history of preterm birth, discuss specific screening protocols with your maternal-fetal medicine specialist. Understanding your individual risk profile is more effective than generalized testing.

Frequently Asked Questions

Is MGen considered a high-risk factor for every pregnant person?

No. While it is a common sexually transmitted infection linked to inflammation, the latest UTHealth Houston study indicates it does not increase the risk of recurrent preterm birth in individuals with a prior history of such complications.

Frequently Asked Questions

Why is Mycoplasma genitalium hard to treat?

According to researchers, the bacteria lack a cell wall. This structural difference makes standard diagnostic tests less effective and complicates the selection of appropriate antibiotics, particularly as the bacteria develop resistance.

Should I be tested for MGen during pregnancy?

Clinical decisions regarding testing should be made in consultation with your OB-GYN. The recent findings suggest that for those at high risk of preterm birth, a positive result does not automatically equate to a higher likelihood of an early delivery.


Have questions about your prenatal health? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on maternal-fetal medicine research.

The Significance of STI Testing: Mycoplasma genitalium and Opt-Out Screening for Chlamydia and Gonor

June 10, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Maternal Vaccination Protects Infants Against RSV Hospitalization

by Chief Editor June 5, 2026
written by Chief Editor

A New Frontier in Infant Health: Maternal RSV Vaccination

Respiratory syncytial virus (RSV) has long been a leading cause of hospitalization for infants in the United States. For years, parents and clinicians lacked a reliable way to protect newborns from the virus starting at birth. However, recent clinical data suggests a significant shift in how we approach neonatal respiratory health.

A New Frontier in Infant Health: Maternal RSV Vaccination
United States

A study published in JAMA Network Open, led by researchers at the University of Pittsburgh and UPMC, provides compelling real-world evidence that maternal vaccination against RSV can drastically reduce the risk of hospitalization for young infants.

Did you know?

Before the approval of the maternal RSVpreF vaccine, there was no standardized method to provide newborns with immediate, reliable protection against RSV from the moment they were born.

Real-World Impact: Reducing Hospitalizations

The research, which analyzed health records from infants 90 days old or younger in western Pennsylvania, found that the maternal RSVpreF vaccine—approved by the U.S. Food and Drug Administration in 2023—is highly effective. Among infants under three months of age, maternal vaccination was associated with approximately 68% effectiveness against hospitalizations for RSV-related respiratory illness.

The findings also highlighted a 69% effectiveness rate against more severe lung infections caused by the virus. As noted by Anne-Marie Rick, M.D., Ph.D., lead author of the study and assistant professor of pediatrics and clinical and translational science at Pitt School of Medicine, the goal was to address the concerns that matter most to families: the potential for their baby to require hospital care.

“The findings show a significant impact for families and for the health system, and it highlights how effective this intervention can be during the most vulnerable months of life,” says Dr. Rick.

Looking Ahead: Expanding the Scope of Research

This breakthrough is part of a larger, ongoing four-year study. Researchers are continuing to track patient outcomes through the 2025–26 and 2026–27 RSV seasons. Future analysis aims to include infants up to 180 days old, providing deeper insights into the duration of the vaccine’s protective effects.

Volunteers Needed For Older Adult RSV Vaccine Study, Or Respiratory Syncytial Virus
Pro Tip:

Real-world data is essential for families and clinicians to make informed medical decisions. Always consult your primary care physician or pediatrician regarding the latest vaccination guidelines for your pregnancy journey.

Frequently Asked Questions (FAQ)

  • What is the RSVpreF vaccine?
    It is a maternal vaccine approved by the FDA in 2023 designed to protect infants from RSV by providing immunity through the mother during pregnancy.
  • How effective is the vaccine for newborns?
    According to recent research, the vaccine is associated with approximately 68% effectiveness against RSV-related hospitalizations in infants younger than 90 days.
  • Why is RSV dangerous for infants?
    RSV is a leading cause of hospitalization for babies in the U.S. Severe cases can lead to complications that require oxygen support or mechanical ventilation.

Join the Conversation

Understanding these advancements is crucial for protecting the next generation. We want to hear from you—how has your experience with pediatric care shaped your views on preventative vaccinations? Share your thoughts in the comments below or subscribe to our health newsletter for the latest updates on medical research and maternal health.

Frequently Asked Questions (FAQ)
Anne-Marie Rick UPMC

For further reading on this study, you can access the full report via the JAMA Network Open publication (DOI: 10.1001/jamanetworkopen.2026.16773).

June 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

UPatch: Transforming Pregnancy Monitoring with Wearable Ultrasound

by Chief Editor May 28, 2026
written by Chief Editor

Breakthrough in Fetal Monitoring: The UPatch Revolutionizes Prenatal Care

Scientists have unveiled a groundbreaking wearable ultrasound device, UPatch, capable of continuously tracking a baby’s health in the womb. This innovation, developed by a team led by Professor Sheng Xu at Stanford University, promises to detect complications that traditional methods often miss.

How UPatch Works: A Game-Changer for Prenatal Care

The UPatch is a stick-on device that can be worn for hours, providing real-time imaging of the fetus and monitoring blood flow, even in dynamic structures like the umbilical cord. In trials involving 62 pregnant participants, the device’s readings matched those of standard handheld ultrasounds, proving its reliability.

Did you know? UPatch’s ability to track fetal blood flow over time could revolutionize how doctors identify issues like pre-eclampsia, a condition that affects 5-8% of pregnancies globally.

Why Current Methods Fall Short

Traditional prenatal monitoring relies on brief snapshots or continuous data riddled with false alarms. UPatch bridges this gap, offering sustained, non-invasive monitoring without constant specialist oversight. For example, in a severe pre-eclampsia case, the device detected alarming blood flow changes, prompting timely intervention.

Why Current Methods Fall Short
Transforming Pregnancy Monitoring Wearable Ultrasound

Expert Insights: Transforming Pregnancy Care

Professor Sheng Xu and his colleagues emphasize UPatch’s potential to reduce unnecessary hospital visits and interventions. “This technology could expand access to prenatal imaging in healthcare deserts,” says first author Dr. Tom Park, highlighting its promise for low-resource settings.

Other researchers, like Dr. Antoniya Georgieva, note that UPatch could shift fetal monitoring from hospital snapshots to everyday wear, offering reassurance to expectant mothers.

Future Developments: From Proof-of-Concept to Wireless Wearables

While UPatch remains a proof-of-concept, future iterations aim to be fully wireless and compact. Researchers stress the need for larger trials to validate its efficacy across diverse populations. If successful, continuous fetal monitoring could become as routine as wearing a smartwatch.

Frequently Asked Questions

What is UPatch?

UPatch is a wearable ultrasound device that continuously monitors fetal health, tracking blood flow and detecting complications in real time.

Wearable ultrasound technology for continuous deep tissue monitoring

How does it differ from traditional ultrasounds?

Unlike brief scans or unreliable continuous data, UPatch provides sustained, non-invasive monitoring, reducing false alarms and improving accuracy.

What are the next steps for UPatch?

Researchers are working on wireless versions and larger clinical trials to ensure safety and effectiveness across diverse populations.

Can UPatch replace traditional prenatal care?

No, but it could complement existing methods, offering real-time insights that enhance decision-making for high-risk pregnancies.

Will UPatch be accessible in low-resource areas?

Developers aim to make it cost-effective and portable, potentially expanding access to prenatal care where specialist sonographers are scarce.

Pro Tips for Expecting Parents

Stay informed about advancements in prenatal technology, and discuss monitoring options with your healthcare provider. Early detection of issues like pre-eclampsia can significantly improve outcomes.

What do you think about wearable technology in pregnancy? Share your thoughts below or subscribe for more updates on medical innovations.

May 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New Wearable Ultrasound Patch Enhances High-Risk Pregnancy Monitoring

by Chief Editor May 26, 2026
written by Chief Editor

For decades, monitoring a high-risk pregnancy has been a game of “snapshots.” Doctors rely on bulky, stationary machines and specialized technicians to capture brief glimpses of fetal health, often leaving parents and physicians in a state of high-stress uncertainty. That paradigm is shifting, thanks to a breakthrough in wearable medical technology that promises to transform prenatal care from intermittent observation into continuous, real-time insight.

The End of “Snapshot” Medicine

The current standard of care—cardiotocography—is notoriously finicky. It requires patients to stay tethered to machines, and even slight movements by the fetus can lead to false alarms or lost signals. For expectant mothers already navigating the anxieties of a high-risk pregnancy, this process is not only labor-intensive but emotionally exhausting.

The End of "Snapshot" Medicine
Risk Pregnancy Monitoring Stanford Medicine

The development of a wearable ultrasound patch, pioneered by researchers at Stanford Medicine and UC San Diego, changes the narrative. By adhering a flexible, palm-sized sticker to the abdomen, clinicians can now track blood flow through the umbilical cord and fetal heart rate continuously. This shift from reactive to proactive monitoring is essential for managing conditions like intrauterine growth restriction (IUGR), which affects roughly 10% of all pregnancies.

Did you know?

Intrauterine growth restriction (IUGR) occurs when a fetus is smaller than expected because We see not receiving enough nutrients or oxygen. Continuous monitoring allows doctors to pinpoint exactly when a “wait-and-see” approach becomes risky, helping them time deliveries to avoid the severe complications of premature birth.

Solving the “Moving Target” Challenge

Creating a wearable ultrasound is a monumental engineering feat. Unlike a smartwatch that tracks a pulse on the surface of the skin, this device must penetrate deep into the uterus to find a target that is constantly moving, twisting, and floating in amniotic fluid.

Solving the "Moving Target" Challenge
Sheng Xu ultrasound patch

The innovation lies in a sophisticated image-segmentation algorithm. By targeting the placenta—the most stable anchoring point for the umbilical cord—the device maintains a lock on the data stream regardless of the mother’s posture or the fetus’s activity. During early validation trials, this technology proved so sensitive that it detected abnormal blood flow patterns in a participant that standard, periodic exams had missed, leading to a successful, timely intervention.

The Road to Remote Fetal Monitoring

While the initial application of this technology is focused on hospital inpatients, the long-term potential is game-changing: at-home fetal monitoring. Just as patients with diabetes now manage their blood glucose levels with wearable sensors, high-risk expectant mothers could soon provide their obstetricians with a continuous data stream from the comfort of their own homes.

Wearable ultrasound technology for continuous deep tissue monitoring

Pro Tip for Healthcare Providers: As wearable diagnostics evolve, prioritize systems that integrate seamlessly with electronic health records (EHR). The value of continuous monitoring is only as good as the clinician’s ability to interpret that data quickly and accurately.

Future Trends in Prenatal Care

The integration of AI and flexible electronics into obstetrics is just beginning. We are moving toward a future where:

Future Trends in Prenatal Care
Sheng Xu ultrasound patch
  • Predictive Analytics: Algorithms will identify subtle shifts in blood flow patterns days before a crisis occurs.
  • Wireless Connectivity: Removing the tether between the patient and the computer will allow for natural movement, reducing stress for the mother.
  • Expanded Diagnostics: Beyond blood flow, future patches may monitor fetal oxygen saturation or complex metabolic markers.

Frequently Asked Questions

Is the wearable ultrasound patch safe for the fetus?
Yes. The device is designed to meet strict safety thresholds for acoustic and mechanical energy established by the FDA and leading medical ultrasound organizations.

Can this device replace traditional ultrasound exams?
Currently, it serves as a complementary tool for continuous monitoring. Standard diagnostic ultrasounds are still required for comprehensive anatomical screenings and complex diagnostic procedures.

When will this be available for home use?
The technology is currently in the research and validation phase. While it shows promise for outpatient use, further clinical trials are necessary before it becomes a standard home-care option.


Are you interested in how medical technology is shaping the future of maternal health? Share your thoughts in the comments below, or subscribe to our newsletter for the latest updates on healthcare innovation.

May 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Persistent Pregnancy Nausea Linked to Anxiety and Depression Risk

by Chief Editor May 26, 2026
written by Chief Editor

For decades, the medical community has categorized pregnancy-related nausea as a routine physical hurdle—a temporary discomfort that signals a “healthy” pregnancy. However, groundbreaking research published in Scientific Reports is shifting this narrative, suggesting that persistent nausea is far more than a physical symptom; it is a vital indicator of a mother’s psychological well-being.

Moving Beyond “Morning Sickness”: The Mental Health Connection

While most clinical discussions focus on hydration and weight loss, new data tracking 424 pregnant women reveals a significant link between the severity of nausea and maternal mental health. Women experiencing persistent, daily nausea often report higher levels of state anxiety and depressive symptoms.

The study utilized the State-Trait Anxiety Inventory (STAI) and the Patient Health Questionnaire-9 (PHQ-9) to quantify this burden. The results were clear: nausea that interferes with daily life is a robust predictor of psychological distress, independent of a patient’s prior psychiatric history.

Did you know?
Nausea and vomiting of pregnancy (NVP) affect between 50% and 80% of all pregnant women. While often expected to resolve by the end of the first trimester, for many, these symptoms persist, creating a “silent” psychological toll that is frequently overlooked during routine prenatal checkups.

Why Clinicians Must Rethink Prenatal Care

The traditional “reassurance model”—where clinicians dismiss a mother’s suffering because the fetus is healthy—is becoming obsolete. The recent study suggests that while nausea may not strongly predict poor birth outcomes, it serves as a “somatic signal” that a patient may require extra mental health support.

View this post on Instagram about Integrated Screening, Multidisciplinary Care
From Instagram — related to Integrated Screening, Multidisciplinary Care

Future trends in obstetrics are likely to include:

  • Integrated Screening: Routine mental health assessments during every prenatal visit, specifically triggered by reports of persistent nausea.
  • Multidisciplinary Care: Closer collaboration between obstetricians and perinatal psychiatrists to address the “emotional load” of pregnancy.
  • Standardized Symptom Tracking: Moving away from subjective “how are you feeling” questions toward validated tools like the Emesis Index (EI) to objectively track the impact on a mother’s daily life.

The Paradox of Physical Health vs. Emotional Well-being

Interestingly, the study found some counterintuitive physical outcomes. Women with early-pregnancy nausea showed a significantly lower incidence of gestational diabetes mellitus (GDM). However, the psychological data remained a clear warning sign.

Morning sickness may be sign of healthy pregnancy, study shows

For expectant mothers, this means that even if your physical markers (like blood sugar and fetal growth) are ideal, your emotional experience is just as important. If your nausea is interfering with your ability to function, it is not just a “normal part of pregnancy”—it is a valid reason to ask for support.

Pro Tip:
If you are struggling with persistent nausea, don’t wait for your provider to bring up mental health. Be proactive: track your symptoms using a journal and bring your specific concerns about anxiety or mood changes to your next appointment. Use terms like “impact on daily functioning” to help your doctor understand the severity.

Frequently Asked Questions (FAQ)

1. Is it normal for nausea to last beyond the first trimester?

While many women find relief after the first 16 weeks, it is medically documented that a significant portion of women experience symptoms well into the second and third trimesters. Persistent symptoms should always be discussed with your healthcare provider.

1. Is it normal for nausea to last beyond the first trimester?
Persistent Pregnancy Nausea Linked Women

2. Can nausea during pregnancy actually cause depression?

Research suggests a strong association. While the exact biological pathways are still being studied, the chronic stress of managing severe nausea can exacerbate anxiety and contribute to depressive symptoms in many women.

3. Should I be worried about my baby if I have severe nausea?

Recent studies suggest that nausea is not a strong predictor of poor birth outcomes. In fact, some data shows lower rates of gestational diabetes in those with early nausea. However, your own health and mental well-being remain a top priority for your care team.

4. What kind of support is available for pregnancy-related anxiety?

Support ranges from cognitive behavioral therapy (CBT) specifically adapted for pregnancy to safe, doctor-approved management strategies for physical symptoms. Always speak to your OB-GYN about your mental health options.


Are you or someone you know navigating the physical and emotional challenges of pregnancy? Share your experiences in the comments below or subscribe to our newsletter for the latest evidence-based insights on maternal health.

May 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Sherbrooke: Train Collides with Car

    July 7, 2026
  • Ximena Capristo’s Shocking Confession About Her Body: ‘I’ve Always Been…

    July 7, 2026
  • Indonesia U-17 Defeats Malaysia 3-0

    July 7, 2026
  • Trump’s Interference Forces FIFA to Suspend Balogun’s Red-Card Ban Amid Political Backlash

    July 7, 2026
  • New Parking Garage Completed at Ostrava University Hospital

    July 7, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top

For contact, advertising, copyright, issues email: [email protected]

Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World